序号 |
标题 |
次数 |
作者 |
发布时间 |
63991 |
SLinPS,cas:322647-11-0,1-硬脂酰-2-亚油酰磷脂酰丝氨酸(钠盐) |
74 |
axc |
2025-01-02 |
63992 |
cas:1353897-91-2,1-棕榈酰基-2-炔丙基乙酰磷脂酰胆碱,1-palmitoyl-2-(propargylacetyl)-sn-glycero-3-phosphocholine |
84 |
axc |
2025-01-02 |
63993 |
DPhPC,cas:207131-40-6,二植酰磷脂酰胆碱 |
79 |
axc |
2025-01-02 |
63994 |
DSPE-MPEG2000,cas:147867-65-0,二硬脂酰磷脂酰乙醇胺-聚乙二醇2000 |
129 |
axc |
2025-01-02 |
63995 |
DPPE,cas:923-61-5,磷脂酰乙醇胺,1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine |
145 |
axc |
2025-01-02 |
63996 |
P-LysoPC,cas:17364-16-8,1-十六酰-sn-丙三醇-磷酸胆碱 |
108 |
axc |
2025-01-02 |
63997 |
DLPC,cas:18194-25-7,1,2-二月桂酰基-sn-glycero-3-胆碱磷酸 |
72 |
axc |
2025-01-02 |
63998 |
HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes,HSPC/Chol/DSPE-mPEG2000/MPL脂质体 |
87 |
axc |
2024-12-31 |
63999 |
DOTAP/DOPE (50/50, mol/mol) Liposomes,DOTAP/DOPE (50/50,摩尔/摩尔)脂质体 |
105 |
axc |
2024-12-31 |
64000 |
Adavosertib Liposomes, Formulation WD4,阿达沃塞替布脂质体,制剂WD4 |
254 |
axc |
2024-12-31 |
64001 |
Mirdametinib (PD0325901) Liposomes, Formulation U6-2,Mirdametinib (PD0325901)脂质体,配方U6-2 |
150 |
axc |
2024-12-31 |
64002 |
DT-061 (SMAP) Liposomes, Formulation TT-40,DT-061 (SMAP)脂质体,制剂TT-40 |
100 |
axc |
2024-12-31 |
64003 |
Tanespimycin (17-AAG) Liposomes, Formulation XT28.1,坦那霉素(17-AAG)脂质体,配方XT28.1 |
99 |
axc |
2024-12-31 |
64004 |
Nexturastat A Liposomes,Nexturastat A脂质体,靶向脂质体定制服务 |
95 |
axc |
2024-12-31 |
64005 |
A939572 Liposomes,A939572脂质体,靶向脂质体定制服务 |
121 |
axc |
2024-12-31 |
64006 |
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2,Eganelisib (IPI-549)脂质体,制剂WNX5.2 |
157 |
axc |
2024-12-31 |
64007 |
Lificiguat (YC-1) Liposomes, Formulation FNT8P.2,Lificiguat (YC-1)脂质体,制剂FNT8P.2 |
83 |
axc |
2024-12-31 |
64008 |
SP600125 Liposomes, Formulation HZ12,SP600125脂质体,配方HZ12 |
98 |
axc |
2024-12-31 |
64009 |
Rocaglamide Liposomes, Formulation KHE9A,罗卡酰胺脂质体,配方KHE9A |
96 |
axc |
2024-12-31 |
64010 |
Gilteritinib (ASP2215) Liposomes,吉尔替尼(ASP2215)脂质体 |
87 |
axc |
2024-12-31 |
64011 |
CAS:125503-35-7 双(2,5-二氧吡咯烷-1-基)2,2'-(丙烷-2,2-二基双(磺胺基)二乙酸酯) |
109 |
zhn |
2024-12-31 |
64012 |
AZD1208 Liposomes, Formulation RB4T4,AZD1208脂质体,配方RB4T4 |
67 |
axc |
2024-12-31 |
64013 |
DiR Labeled Tumor-Accumulating Liposomes邃,DiR标记的肿瘤积聚脂质体 |
93 |
axc |
2024-12-31 |
64014 |
氧化锌量子点(ZnO QDs) 无机半导体材料 |
177 |
zhn |
2024-12-31 |
64015 |
聚多巴胺微球 |
166 |
zhn |
2024-12-31 |
64016 |
PS-R-PMMA 聚苯乙烯(PS)和聚甲基丙烯酸甲酯(PMMA)共聚物 |
286 |
zhn |
2024-12-31 |
64017 |
AgBiS₂量子点 银铋硫化物量子点 |
114 |
zhn |
2024-12-31 |
64018 |
单层石墨相氮化碳纳米片(Graphitic Carbon Nitride, g-C₃N₄) |
227 |
zhn |
2024-12-31 |
64019 |
HSPC/胆固醇/DSPE-mPEG2000 (56.2/38.5/5.3,摩尔/摩尔)脂质体(DiD标记),脂质体定制服务 |
119 |
axc |
2024-12-31 |
64020 |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes (DiD-labeled),脂质体定制服务 |
123 |
axc |
2024-12-31 |
64021 |
环糊精修饰螺吡类分子 |
80 |
zhn |
2024-12-31 |
64022 |
HSPC/胆固醇/DSPE-聚乙二醇2000/DSPE-聚乙二醇2000-马来酰亚胺(50/45/4/1,摩尔/摩尔)脂质体,脂质体定制服务 |
118 |
axc |
2024-12-31 |
64023 |
二氧化硅包纳米金棒 SiO₂@Au nanorods |
97 |
zhn |
2024-12-31 |
64024 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes,脂质体定制服务 |
123 |
axc |
2024-12-31 |
64025 |
四氧化三铁二硫化钼复合材料 Fe₃O₄@MoS₂ |
222 |
zhn |
2024-12-31 |
64026 |
17-(Azide-PEG9-ethylcarbamoyl)heptadecanoic t-butyl ester |
79 |
h |
2024-12-31 |
64027 |
14-(Azide-PEG6-ethylcarbamoyl)tridecanoic-t-butyl ester |
69 |
h |
2024-12-31 |
64028 |
IR-700-NH2 氨基化的近红外荧光染料 |
161 |
zhn |
2024-12-31 |
64029 |
HSPC/Chol/DSPE-mpeg 2000/DSPE-mpeg 2000-马来酰亚胺/MPL (49/45/4/1/1,摩尔/摩尔)脂质体,脂质体定制服务 |
85 |
axc |
2024-12-31 |
64030 |
14-(Azide-PEG4-ethylcarbamoyl)tridecanoic-t-butyl ester |
83 |
h |
2024-12-31 |
64031 |
Amine-PEG5-c18-t-butyl ester |
137 |
h |
2024-12-31 |
64032 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide/MPL(49/45/4/1/1, mol/mol) Liposomes,脂质体定制服务 |
143 |
axc |
2024-12-31 |
64033 |
PS22500-EHA100000-PS22500 一种嵌段共聚物 |
87 |
zhn |
2024-12-31 |
64034 |
16-(Amine-PEG3-ethylcarbamoyl)pentadecanoic-t-butyl ester |
115 |
h |
2024-12-31 |
64035 |
PCN-224 金属有机骨架 |
537 |
zhn |
2024-12-31 |